Found: 203
Select item for more details and to access through your institution.
FDA backs clinician-free AI imaging diagnostic tools.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 8, p. 673, doi. 10.1038/nbt0818-673a
- By:
- Publication type:
- Article
Publisher Correction: Light-activated genetic therapy to treat blindness enters clinic.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Light-activated genetic therapy to treat blindness enters clinic.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 2, p. 126, doi. 10.1038/s41587-021-00823-9
- By:
- Publication type:
- Article
Microbial cocktails raise bar for C. diff. treatments.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 12, p. 1366, doi. 10.1038/s41587-020-00765-8
- By:
- Publication type:
- Article
Quantum embedding for material chemistry based on domain separation and open subsystems.
- Published in:
- International Journal of Quantum Chemistry, 2020, v. 120, n. 21, p. 1, doi. 10.1002/qua.26184
- By:
- Publication type:
- Article
Two-photon excited deep-red and near-infrared emissive organic co-crystals.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18431-7
- By:
- Publication type:
- Article
Patients with porphyria bask in sunlight of FDA approval.
- Published in:
- Nature Biotechnology, 2019, v. 37, n. 12, p. 1390, doi. 10.1038/s41587-019-0347-0
- By:
- Publication type:
- Article
FDA approves first single-dose antimalarial.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 10, p. 785, doi. 10.1038/nbt0918-785a
- By:
- Publication type:
- Article
FDA approves first single-dose antimalarial.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 9, p. 785, doi. 10.1038/nbt0918-785a
- By:
- Publication type:
- Article
FDA backs clinician-free AI imaging diagnostic tools.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 8, p. 673, doi. 10.1038/nbt0818-673a
- By:
- Publication type:
- Article
Next-generation sequencing tests to become routine.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 6, p. 484, doi. 10.1038/nbt0618-484
- By:
- Publication type:
- Article
Jury out on liquid biopsies for cancer.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 3, p. 209, doi. 10.1038/nbt0318-209a
- By:
- Publication type:
- Article
Approval of first tumor gene panel sends shockwaves through labs.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 2, p. 124, doi. 10.1038/nbt0218-124
- By:
- Publication type:
- Article
FDA to relax grip on at-home genetic tests, but concerns linger.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 1, p. 10, doi. 10.1038/nbt0118-10
- By:
- Publication type:
- Article
Amgen cholesterol antibody feud could kill key IP rule.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 12, p. 1118, doi. 10.1038/nbt1217-1118
- By:
- Publication type:
- Article
A Silicon Ratchet to Produce Power from Below-Bandgap Photons.
- Published in:
- Advanced Energy Materials, 2017, v. 7, n. 22, p. n/a, doi. 10.1002/aenm.201701000
- By:
- Publication type:
- Article
First multi-gene NGS diagnostic kit approved.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 8, p. 699, doi. 10.1038/nbt0817-699
- By:
- Publication type:
- Article
FDA deems in vitro data on mutations sufficient to expand cystic fibrosis drug label.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 7, p. 606, doi. 10.1038/nbt0717-606
- By:
- Publication type:
- Article
Cover Picture: A Study of Electrocyclic Reactions in a Molecular Junction: Mechanistic and Energetic Requirements for Switching in the Coulomb Blockade Regime (ChemPhysChem 12/2017).
- Published in:
- ChemPhysChem, 2017, v. 18, n. 12, p. 1491, doi. 10.1002/cphc.201700613
- By:
- Publication type:
- Article
A Study of Electrocyclic Reactions in a Molecular Junction: Mechanistic and Energetic Requirements for Switching in the Coulomb Blockade Regime.
- Published in:
- ChemPhysChem, 2017, v. 18, n. 12, p. 1492, doi. 10.1002/cphc.201700612
- By:
- Publication type:
- Article
A Study of Electrocyclic Reactions in a Molecular Junction: Mechanistic and Energetic Requirements for Switching in the Coulomb Blockade Regime.
- Published in:
- ChemPhysChem, 2017, v. 18, n. 12, p. 1517, doi. 10.1002/cphc.201700140
- By:
- Publication type:
- Article
Genomics pioneer gets its first drug.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 5, p. 399, doi. 10.1038/nbt0517-399
- By:
- Publication type:
- Article
Trade groups laud Gottlieb FDA choice, silent on NIH cutback.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 4, p. 293, doi. 10.1038/nbt0417-293
- By:
- Publication type:
- Article
Gate-controlled conductance switching in DNA.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14471, doi. 10.1038/ncomms14471
- By:
- Publication type:
- Article
Seres's pioneering microbiome drug fails mid-stage trial.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 10, p. 1004, doi. 10.1038/nbt1016-1004b
- By:
- Publication type:
- Article
Strata rolls out drug-matching service, offers free tumor profiling.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 9, p. 895, doi. 10.1038/nbt0916-895
- By:
- Publication type:
- Article
Genentech's PD-L1 agent approved for bladder cancer.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 8, p. 789, doi. 10.1038/nbt0816-789
- By:
- Publication type:
- Article
Gilead bets big on Nimbus' fatty liver disease drug.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 6, p. 575, doi. 10.1038/nbt0616-575
- By:
- Publication type:
- Article
Sanofi drops MannKind's inhaled insulin.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 3, p. 224, doi. 10.1038/nbt0316-224
- By:
- Publication type:
- Article
FDA approves three different multiple myeloma drugs in one month.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 2, p. 126, doi. 10.1038/nbt0216-126
- By:
- Publication type:
- Article
Off-the-shelf CAR-T therapy induces remission in child with ALL.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 1, p. 12, doi. 10.1038/nbt0116-12
- By:
- Publication type:
- Article
Piezoresistivity in single DNA molecules.
- Published in:
- Nature Communications, 2015, v. 6, n. 9, p. 8032, doi. 10.1038/ncomms9032
- By:
- Publication type:
- Article
Microbial cocktails join fecal transplants in IBD treatment trials.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 8, p. 787, doi. 10.1038/nbt0815-787
- By:
- Publication type:
- Article
Alexion pays big for Synageva's rare disease drug candidate.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 7, p. 679, doi. 10.1038/nbt0715-679
- By:
- Publication type:
- Article
Emergent Properties in Locally Ordered Molecular Materials.
- Published in:
- Israel Journal of Chemistry, 2015, v. 55, n. 6, p. 454, doi. 10.1002/ijch.201400021
- By:
- Publication type:
- Article
Heart failure gene therapy disappoints but experts keep the faith.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 6, p. 573, doi. 10.1038/nbt0615-573a
- By:
- Publication type:
- Article
Biogen's early Alzheimer's data raise hopes, some eyebrows.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 5, p. 438, doi. 10.1038/nbt0515-438
- By:
- Publication type:
- Article
Roche spends $1 billion on Foundation Medicine's tumor profiling.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 3, p. 215, doi. 10.1038/nbt0315-215
- By:
- Publication type:
- Article
Intermediate tunnelling-hopping regime in DNA charge transport.
- Published in:
- Nature Chemistry, 2015, v. 7, n. 3, p. 221, doi. 10.1038/nchem.2183
- By:
- Publication type:
- Article
The Scope and Limitations of Ternary Blend Organic Photovoltaics.
- Published in:
- Advanced Energy Materials, 2015, v. 5, n. 3, p. n/a, doi. 10.1002/aenm.201400891
- By:
- Publication type:
- Article
Roche swallows Ariosa, grabs slice of prenatal test market.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 2, p. 113, doi. 10.1038/nbt0215-113
- By:
- Publication type:
- Article
Towards graphyne molecular electronics.
- Published in:
- Nature Communications, 2015, v. 6, n. 2, p. 6321, doi. 10.1038/ncomms7321
- By:
- Publication type:
- Article
IL-17-targeting biologics aim to become standard of care in psoriasis.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 1, p. 3, doi. 10.1038/nbt0115-3
- By:
- Publication type:
- Article
IBM's Watson Group signs up genomics partners.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 1, p. 10, doi. 10.1038/nbt0115-10
- By:
- Publication type:
- Article
Celgene wagers on Sutro's cell-free platform to ramp up ADCs.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 12, p. 1175, doi. 10.1038/nbt1214-1175
- By:
- Publication type:
- Article
Landmark approvals in idiopathic pulmonary fibrosis.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 11, p. 1069, doi. 10.1038/nbt1114-1069
- By:
- Publication type:
- Article
Pharma partners with efforts to pool patient genotype and phenotype data.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 967, doi. 10.1038/nbt1014-967
- By:
- Publication type:
- Article
Small biotech steers HDAC inhibitor to clinic.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 9, p. 853, doi. 10.1038/nbt0914-853
- By:
- Publication type:
- Article
FDA pushes for control over laboratory-developed tests.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 9, p. 855, doi. 10.1038/nbt0914-855a
- By:
- Publication type:
- Article
Next-generation AMD drugs to wed blockbusters.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 8, p. 701, doi. 10.1038/nbt0814-701
- By:
- Publication type:
- Article